Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonabersat single- and multiple-ascending dose placebo-controlled study in healthy adults
NL-OMON36253Active, not recruiting
- Sponsor
- Upsher-Smith Laboratories
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tonabersat in migraine (11 cohorts), sponsored by Upsher-Smith Laboratories. Primary endpoints: Cognitive and psychomotor performance, EEG parameters and 11 more. Started Jan 2010; status: active, not recruiting.
02
Drugs
tonabersat
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON36253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36253.